MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India - (The Economic Times via NewsPoints Desk)

  • MSD Pharmaceuticals has launched the first gender-neutral HPV vaccine, GARDASIL 9, in India, as reported by The Economic Times.

  • The 9-valent human papillomavirus vaccine will help reduce the disease burden and cancers caused by the HPV types among girls and women ages 9 to 26 and boys ages 9 to 15.

  • "Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," remarked MSD India Region Managing Director Rehan A Khan.

To read more NewsPoints articles, click here.